Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancerWei Nie(Guangdong Polytechnic of Science and Technology), Bing Li(Wuhan University)Laboratory InvestigationNovember 10, 201410.1038/labinvest.2014.124Cited by 78SaveCiteExport RISWatch citationsRelated PapersMiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer|Lung Cancer|2013|178Soluble Programmed Cell Death-1 is a Novel Predictor of HBsAg Loss in Chronic Hepatitis B Patients When Long-Term Nucleos(t)ide Analog Treatment is Discontinued|Infection and Drug Resistance|2022|6